Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Oct-Dec;12(4):426-434.
doi: 10.25122/jml-2019-0108.

The Severity of Oxidative Stress in Comorbid Chronic Obstructive Pulmonary Disease (COPD) and Hypertension: Does it Depend On ACE and AGT Gene Polymorphisms?

Mariya Marushchak  1 , Khrystyna Maksiv  2 , Inna Krynytska  1 , Olha Dutchak  3 , Nina Behosh  1
Affiliations

The Severity of Oxidative Stress in Comorbid Chronic Obstructive Pulmonary Disease (COPD) and Hypertension: Does it Depend On ACE and AGT Gene Polymorphisms?

Mariya Marushchak et al. J Med Life. 2019 Oct-Dec.

Abstract

There is an increasing number of studies suggesting the role of genetic factors in the development and progression of chronic obstructive pulmonary disease and hypertension. Therefore, our study aimed to establish the role of ACE and AGT gene polymorphisms in the mechanisms behind the development of oxidative stress in patients with concomitant chronic obstructive pulmonary disease and hypertension. The study group consisted of 96 patients: Group 1 (individuals with a chronic obstructive pulmonary disease), Group 2 (individuals with arterial hypertension), Group 3 (individuals with a chronic obstructive pulmonary disease and arterial hypertension). The control group consisted of 20 healthy subjects. ACE and AGT gene polymorphisms were determined by polymerase chain reaction amplification. Detection of intracellular reactive oxygen species levels was performed by EPICS XL cytometer (Beckman Coulter, USA) with dichlorodihydrofluorescein diacetate and dihydroethidium. Serum levels of 8-isoprostane were assayed with ELISA, Cayman Chemicals (USA). No significant correlations between ACE and AGT gene polymorphisms and parameters of oxidative stress in a setting of comorbid chronic obstructive pulmonary disease and hypertension were observed. However, the increase in oxidative stress parameters was observed to be the most significant in patients with chronic obstructive pulmonary disease + hypertension and with I/I genotype of the ACE gene, which was due to their lowest values in virtually healthy individuals. This suggests that I/I genotype may be associated with lower levels of reactive oxygen species production compared with other genotypes.

Keywords: ACE - Angiotensin-Converting Enzyme; AGT - Angiotensinogen; COPD; COPD - Chronic Obstructive Pulmonary Disease; H2O2 - Hydrogen Peroxide; O2• - Superoxide; ROS - Reactive Oxygen Species; gene polymorphism; hypertension; oxidative stress.

PubMed Disclaimer

Figures

Figure 1:
Figure 1:
The percentage ratio of changes in oxidative stress parameters within one genotype of the ACE gene.
Figure 2:
Figure 2:
The percentage ratio of changes in oxidative stress parameters within one genotype of the AGT gene.
See this image and copyright information in PMC

References

    1. Hatipoğlu U. Chronic obstructive pulmonary disease: More than meets the eye. Ann Thorac Med. 2018;13(1):1–6. - PMC - PubMed
    1. Rubinsztajn R, Przybyłowski T, Karwat K, Maskey-Warzęchowska M, Chazan R. Patients with chronic obstructive pulmonary disease (COPD) – similarities and differences of the study group participating in the project of National Center for Research and Development project “Chronic obstructive pulmonary disease (COPD) – systemic disease, the biggest threat of XXI century”. Pol Med J. 2015;XXXIX(234):359–363. - PubMed
    1. Marushchak M, Maksiv K, Krynytska I. ACE gene I/D polymorphism and arterial hypertension in patients with COPD. Pneumologia. 2019;68:1–6.
    1. Morgan AD, Zakeri R, Quint JK. Defining the relationship between COPD and CVD: what are the implications for clinical practice? Ther Adv Respir Dis. 2018 doi: 10.1177/1753465817750524. - DOI - PMC - PubMed
    1. Miravitlles M, Vogelmeier C, Roche N, Halpin D, Cardoso J, Chuchalin AG, Kankaanranta H, Sandström T, Śliwiński P, Zatloukal J, Blasi F. A review of national guidelines for management of COPD in Europe. Eur Respir J. 2016;47(2):625–637. - PMC - PubMed